VYVGART is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Argenx Us. The primary component is Efgartigimod Alfa.
| Product ID | 73475-3041_03a14315-608c-4b82-a667-526841d98ea7 |
| NDC | 73475-3041 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VYVGART |
| Generic Name | Efgartigimod Alfa |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-12-17 |
| Marketing Category | BLA / |
| Application Number | BLA761195 |
| Labeler Name | argenx US |
| Substance Name | EFGARTIGIMOD ALFA |
| Active Ingredient Strength | 20 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-12-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VYVGART 98008004 not registered Live/Pending |
Argenx B.V. 2023-05-22 |
![]() VYVGART 90061747 not registered Live/Pending |
Argenx B.V. 2020-07-20 |